Sodium Acetate NDC 71357-009

NDC codes

FDA NDC Directory

Product NDC (as listed)71357-009Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71357-0009Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71357-009-10	71357000910	10 VIAL, PHARMACY BULK PACKAGE in 1 CASE (71357-009-10) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE (71357-009-01)Marketed from Dec 6, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Acetate
Generic name (nonproprietary): sodium acetate injection, usp, 400 meq/100 ml
Active ingredients: Sodium acetate — 400 meq/100mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: MILLA PHARMACEUTICALS INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214805
Marketing start: Dec 6, 2024
Listing expires: Dec 31, 2027
Identifiers: Product ID 71357-009_47d8d0e7-6db5-950d-e063-6294a90ab1bfSPL ID 47d8d0e7-6db5-950d-e063-6294a90ab1bfSPL set ID 1ea1466d-a492-4056-e063-6394a90a80bfRxCUI 237371, 312965UNII 4550K0SC9BUPC 0371357008019, 0371357008101, 0377357002019

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N471357000910 followed by a unit qualifier and the quantity

Package 71357-0009-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 7, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sodium Acetate Injection, USP is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214805

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214805
Product	Strength	Form · route	Labeler	Product NDC
Sodium Acetate	Sodium acetate 164 mg/mL	Injection, Solution, ConcentrateIntravenous	MILLA PHARMACEUTICALS INC.	71357-007
Sodium Acetate	Sodium acetate 164 mg/mL	Injection, Solution, ConcentrateIntravenous	MILLA PHARMACEUTICALS INC.	71357-002
Sodium Acetatesodium acetate injection, usp, 200 meq/100 ml	Sodium acetate 200 meq/100mL	Injection, Solution, ConcentrateIntravenous	MILLA PHARMACEUTICALS INC.	71357-008